Monika Beličková

3.0k total citations
57 papers, 1.1k citations indexed

About

Monika Beličková is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Monika Beličková has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 33 papers in Molecular Biology and 15 papers in Cancer Research. Recurrent topics in Monika Beličková's work include Acute Myeloid Leukemia Research (35 papers), MicroRNA in disease regulation (9 papers) and Cancer-related molecular mechanisms research (8 papers). Monika Beličková is often cited by papers focused on Acute Myeloid Leukemia Research (35 papers), MicroRNA in disease regulation (9 papers) and Cancer-related molecular mechanisms research (8 papers). Monika Beličková collaborates with scholars based in Czechia, United States and Poland. Monika Beličková's co-authors include Michaela Dostálová Merkerová, Hana Bruchova, Jaroslav Čermák, Alžběta Vašíková, Hana Votavová, Zdeněk Krejčík, Anna Jonášová, R Neuwírtová, Zuzana Zemanová and K Michalová and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and International Journal of Cancer.

In The Last Decade

Monika Beličková

56 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monika Beličková Czechia 18 650 466 441 217 144 57 1.1k
Anna Jonášová Czechia 16 411 0.6× 588 1.3× 196 0.4× 240 1.1× 103 0.7× 76 876
Nicolas Duployez France 17 375 0.6× 621 1.3× 135 0.3× 303 1.4× 93 0.6× 67 950
Iris H.I.M. Hollink Netherlands 19 684 1.1× 848 1.8× 162 0.4× 144 0.7× 116 0.8× 35 1.2k
Saman Abbas Netherlands 8 676 1.0× 619 1.3× 242 0.5× 234 1.1× 46 0.3× 10 1.1k
Matthias Bartenstein United States 8 387 0.6× 252 0.5× 196 0.4× 125 0.6× 118 0.8× 16 661
Daichi Inoue Japan 16 473 0.7× 482 1.0× 84 0.2× 212 1.0× 115 0.8× 55 864
Kathy L. McGraw United States 18 558 0.9× 756 1.6× 125 0.3× 343 1.6× 308 2.1× 53 1.2k
Ann‐Kathrin Eisfeld United States 19 519 0.8× 563 1.2× 303 0.7× 193 0.9× 78 0.5× 64 1.0k
Yukiko Komeno Japan 20 549 0.8× 445 1.0× 87 0.2× 131 0.6× 189 1.3× 44 984
Fen‐Yu Lee Taiwan 14 578 0.9× 918 2.0× 192 0.4× 432 2.0× 95 0.7× 20 1.2k

Countries citing papers authored by Monika Beličková

Since Specialization
Citations

This map shows the geographic impact of Monika Beličková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Beličková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Beličková more than expected).

Fields of papers citing papers by Monika Beličková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monika Beličková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Beličková. The network helps show where Monika Beličková may publish in the future.

Co-authorship network of co-authors of Monika Beličková

This figure shows the co-authorship network connecting the top 25 collaborators of Monika Beličková. A scholar is included among the top collaborators of Monika Beličková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Beličková. Monika Beličková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krejčík, Zdeněk, Jǐŕı Kléma, Monika Beličková, et al.. (2025). Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms. Biomarker Research. 13(1). 13–13. 1 indexed citations
2.
Votavová, Hana, Michaela Dostálová Merkerová, Zdeněk Krejčík, et al.. (2024). Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower‐risk myelodysplastic neoplasms. International Journal of Cancer. 154(9). 1652–1668. 3 indexed citations
3.
Stibůrková, Blanka, Kateřina Pavelcová, Monika Beličková, et al.. (2023). Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome. Arthritis & Rheumatology. 75(7). 1285–1290. 33 indexed citations
4.
Votavová, Hana, et al.. (2023). Hypoplastic form of myelodysplastic neoplasm. Klinicka onkologie. 36(3). 206–214. 2 indexed citations
5.
Beličková, Monika, et al.. (2023). Different Mutations in SF3B1 Gene Have Specific Transcriptomic Characteristics in Myelodysplastic Neoplasms. Blood. 142(Supplement 1). 3218–3218.
6.
Šálek, Cyril, et al.. (2023). ABC transporters are predictors of treatment failure in acute myeloid leukaemia. Biomedicine & Pharmacotherapy. 170. 115930–115930. 7 indexed citations
7.
Votavová, Hana, Michaela Dostálová Merkerová, Zdeněk Krejčík, et al.. (2022). RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS. Leukemia. 36(7). 1898–1906. 15 indexed citations
8.
Merkerová, Michaela Dostálová, Jǐŕı Kléma, Zdeněk Krejčík, et al.. (2022). Noncoding RNAs and Their Response Predictive Value in Azacitidine-treated Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-related Changes. Cancer Genomics & Proteomics. 19(2). 205–228. 7 indexed citations
9.
Beličková, Monika, Michaela Dostálová Merkerová, Zdeněk Krejčík, et al.. (2021). Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34+ Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients. Cancers. 13(9). 2161–2161. 2 indexed citations
10.
Votavová, Hana, et al.. (2021). Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients. Pharmaceuticals. 14(1). 41–41. 5 indexed citations
11.
Krejčík, Zdeněk, Jǐŕı Kléma, Monika Beličková, et al.. (2020). LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome. Cancers. 12(10). 2726–2726. 21 indexed citations
12.
Krejčík, Zdeněk, Monika Beličková, Jǐŕı Kléma, et al.. (2020). Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome. Cells. 9(4). 794–794. 33 indexed citations
13.
Beličková, Monika, Jana Březinová, Magda Šišková, et al.. (2020). Cryptic aberrations may allow more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution. Genes Chromosomes and Cancer. 59(7). 396–405. 1 indexed citations
14.
Votavová, Hana, et al.. (2019). Genetic Variant Screening of DNA Repair Genes in Myelodysplastic Syndrome Identifies a Novel Mutation in the <b><i>XRCC2</i></b> Gene. Oncology Research and Treatment. 42(5). 263–268. 3 indexed citations
15.
16.
Beličková, Monika, Michaela Dostálová Merkerová, Hana Votavová, et al.. (2016). Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms. International Journal of Hematology. 104(5). 566–573. 11 indexed citations
17.
Merkerová, Michaela Dostálová, Monika Beličková, Zdeněk Krejčík, et al.. (2012). From cryptic chromosomal lesions to pathologically relevant genes: Integration of SNP‐array with gene expression profiling in myelodysplastic syndrome with normal karyotype. Genes Chromosomes and Cancer. 51(5). 419–428. 11 indexed citations
18.
Merkerová, Michaela Dostálová, Zdeněk Krejčík, Hana Votavová, et al.. (2010). Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome. European Journal of Human Genetics. 19(3). 313–319. 63 indexed citations
19.
Merkerová, Michaela Dostálová, Alžběta Vašíková, Monika Beličková, & Hana Bruchova. (2009). MicroRNA Expression Profiles in Umbilical Cord Blood Cell Lineages. Stem Cells and Development. 19(1). 17–26. 69 indexed citations
20.
Neuwírtová, R, Monika Beličková, Jiřina Bartůňková, et al.. (2009). Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome. Experimental Hematology. 37(3). 386–394. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Jonášová Breakdown of academic impact, for papers by Nicolas Duployez Breakdown of academic impact, for papers by Iris H.I.M. Hollink Breakdown of academic impact, for papers by Saman Abbas Breakdown of academic impact, for papers by Matthias Bartenstein Breakdown of academic impact, for papers by Daichi Inoue Breakdown of academic impact, for papers by Kathy L. McGraw Breakdown of academic impact, for papers by Ann‐Kathrin Eisfeld Breakdown of academic impact, for papers by Yukiko Komeno Breakdown of academic impact, for papers by Fen‐Yu Lee
Rankless by CCL
2026